Article
Boston — New research discoveries demonstrate that melanoma is highly dependent on cyclin-dependent kinase 2 (CDK2) for growth and proliferation. Inhibiting expression of the gene regulating CDK2 stops the cancer dead in its tracks.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.